SLC3A2 and laryngeal carcinoma: As shown in Fig. 2B, SLC3A2 was highly expressed in laryngeal carcinoma compared with normal (p < 0.001), and patients with high SLC3A2 expression showed a poor fraction survival (p = 0.045).